Thus, concerning MS/EAE, evidence suggests that potentiation of A1R and blockade of A2AR-mediated adenosine actions induce strong neuroprotective actions via the attenuation of glial cells’ reactivity [15,18,19,20,21,22]. Here, ADORA2A is linked to myeloid sarcoma.